Since EA has been shown to improve insulin activity in our previous studies [12, 13], a combination of EA's effects in terms of enhancing insulin activity with the use of an insulin sensitizer may potentially be a new modality for the treatment of diabetes mellitus in humans [14]. This evidence concerns the gene INS and diabetes mellitus.